Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide nuclesome occupancy following HDAC inhbitor and/or doxorubicin treatment

ABSTRACT: The goal of this study is to identify nucleosome occupancies in leukemic cells treated with either HDAC inhibitor or doxorubicin or HDAC inhibitor plus doxorubicin

ORGANISM(S): Homo sapiens

PROVIDER: GSE86784 | GEO | 2021/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Next Generation Sequencing of RNA from HDAC inhibitor and/or doxorubicin treated samples

Project description:Our study represents the first detailed analysis of transcriptomes in HDAC inhibitor and doxorubicin treated leukemic cells. The goal of this study is to identify gene expression patterns in HDAC and/or doxorubicin treated leukemic cells

2021-07-01 | GSE86783 | GEO

Genome-wide nuclesome occupancy following HDAC1,2 inhibitor treatment

Project description:The goal of this study is to identify nucleoosme occupancies in leukemic cells treated with HDAC1,2 inhibitor

2021-07-01 | GSE99442 | GEO

Analysis of genome maintenance in Philadelphia-positive leukemia following HDAC inhibition and doxorubicin treatment

Project description:Analysis of genome maintenance in Philadelphia-positive leukemia following HDAC inhibition and doxorubicin treatment

| PRJNA342491 | ENA

Gene expression and H3K9ac genome-wide maps following HDAC inhibition in mouse ES cells

Project description:This SuperSeries is composed of the following subset Series: GSE23956: Gene expression profiles of E14 ESCs treated with low levels of HDAC inhibitors for 16 hrs GSE23957: Gene expression profiles of E14 ESCs treated with low levels of the HDAC inhibitor VPA for 4 hrs GSE24211: Genome-wide H3K9 acetylation state before and after VPA treatment Refer to individual Series

2011-09-16 | E-GEOD-23958 | biostudies-arrayexpress

SK-MEL-2 cells treated with Ad-E2F-1, Ad-E2F-1 plus doxorubicn or Ad-LacZ plus doxorubicin

Project description:SK-MEL-2 cells treated with Ad-E2F-1 (MOI 2), Ad-E2F-1 (MOI 2)plus doxorubicin 0.1uM, or Ad-LacZ (MOI 2) plus doxorubicin 0.1uM Keywords: ordered

2005-06-03 | GSE2715 | GEO

Detoxifying doxorubicin

Project description:Detoxifying doxorubicin

| PRJNA422761 | ENA

Molecular changes in cancer cells exposed to an HDAC inhibitor: A metabolomics approach

Project description:Histone deacetylase (HDAC) inhibitors are part of a new generation of epigenetic drugs for cancer treatment. It is known that histone acetylation plays a key role in controlling essential chromosome functions, including gene regulation, and this process has been linked with cancer development and progression. Better understanding of molecular mechanisms involving HDAC inhibitors is needed for the design of new targeted drugs, and also to evaluate the effectiveness of current treatments. In this study, an untargeted metabolomics approach was used to identify intracellular metabolite deregulation after treating cancer cell lines with the HDAC inhibitor HC-Toxin. Metabolomics analysis was performed using high resolution mass spectrometry, in combination with univariate and multivariate statistics and pathway analysis. HDAC inhibition showed highly specific metabolic changes in cancer cell lines compared to non-cancerous cells. In particular, N-acetyl-L-cysteine, N-acetylmethionine, and N-acetyl-L-carnitine showed a dose dependent change. Moreover, pathways controlling protein biosynthesis, as well as tryptophan, cysteine and methionine metabolism were significantly altered by HDAC inhibition. This study illustrates that HDAC inhibition has multiple effects on different metabolic pathways and our results can be extrapolated to inform on the molecular transitions in human cells.

2022-05-04 | MTBLS682 | MetaboLights

Expression data comparing chemoresistant (cisplatin and doxorubicin) hepatospheres and differentiated HCC cells

Project description:To identify candidate genes that are up-regulated in chemoresistant (cisplatin and doxorubicin) hepatospheres as compared with their differentiated counterparts Affymetrix Human Genome U133 Plus GeneChip 2.0

2014-06-01 | GSE53005 | GEO

Effect of HDAC inhibitor TSA on haploid embryogenesis [dataset 1]

Project description:Haploid embryos can be induced from cultured immature pollen following a stress treatment. In Brassica napus, application of the histone/lysine deacetylase (HDAC/KDAC) inhibitor trichostatin A (TSA) to pollen cultures enhances the production of differentiated embryos and embryogenic callus when applied together with heat stress (Li et al., 2014). To identify genes associated with the induction of B. napus haploid embryogenesis, we compared the transcriptomes of untreated pollen cultures and pollen cultures treated with either heat-stress or heat-stress plus TSA.

2020-08-03 | GSE140969 | GEO

Gene Expression Profiles of Epigenetic treatment in primary breast cancer.

Project description:Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases (HDACs) is at present undergoing clinical testing in cancer therapy. As epigenetic alterations are common to breast cancer, in this proof-of-concept study demethylating hydralazine plus the HDAC inhibitor magnesium valproate were added to neoadjuvant doxorubicin and cyclophosphamide in locally advanced breast cancer to assess their safety and biological efficacy. Keywords: Epigenetic treatment, Hydralazine, valproate, breast cancer

2006-11-18 | GSE6304 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data